Biocept Q3 Revenues Spike Sharply With COVID-19 Testing Dwarfing Core Cancer Tests


NEW YORK – Biocept reported after the close of the market on Thursday that its third quarter revenues more than quadrupled year over year driven by its current offering of molecular COVID-19 testing services.

For the three months ended Sept. 30, the San Diego-based liquid biopsy company posted $6.6 million in revenues compared to $1.5 million in Q3 2019.



Source link

Get in Touch

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

VIRUS TRACKER – Nov. 26: 120 New COVID-19 Cases In Hawaii

Health officials reported 120 new COVID-19 cases statewide on Thursday and the deaths of two people...

Tracking COVID-19 in Alaska: 4 deaths and 563 new cases reported Thursday

We're making this important information about the pandemic available without a subscription as a public service. But we...

COVID-19 Impact and Recovery Analysis | Immigration Services Market Procurement Intelligence Report Forecasts Spend Growth of Over USD 49 Billion

LONDON--(BUSINESS WIRE)--The Immigration Services Market is poised to experience a spend growth of more than USD...

Get in Touch

0FansLike
2,455FollowersFollow
0SubscribersSubscribe

Latest Posts

VIRUS TRACKER – Nov. 26: 120 New COVID-19 Cases In Hawaii

Health officials reported 120 new COVID-19 cases statewide on Thursday and the deaths of two people...

Tracking COVID-19 in Alaska: 4 deaths and 563 new cases reported Thursday

We're making this important information about the pandemic available without a subscription as a public service. But we...

COVID-19 Impact and Recovery Analysis | Immigration Services Market Procurement Intelligence Report Forecasts Spend Growth of Over USD 49 Billion

LONDON--(BUSINESS WIRE)--The Immigration Services Market is poised to experience a spend growth of more than USD...

Nutritional quality seen in movies gets 2 thumbs down

When it comes to a child’s diet, there are many factors that can determine what it consists of and whether it’s healthful, such as...

Results Of Coronavirus Vaccine Trial Questioned After AstraZeneca Admits A Mistake – NPR

Results Of Coronavirus Vaccine Trial Questioned After AstraZeneca Admits A Mistake  NPRSource link
Supportscreen tag
%d bloggers like this: